Personal
Become a Client
Vanda Pharmaceuticals Inc (USD)
VNDA
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range17.38 | 18.10
52-Wk Range- | -
Last Close17.86
Mkt Cap (m)992.38
Dividend yield-
ISINUS9216591084
Volume84,947.00
Exchange VenueNAS

Company Profile

Vanda Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders to address unmet needs.

Key Information
Price/Earning31.89
Price/Book2.12
Price/Sales3.93
P/CF16.05
Rev Growth (3 year avg)14.56
EPS Growth (3 year avg)-
Operating Margin % 10.98
Net Margin %9.40
Return on Equity5.40
Debt/Equity0.03

Documents

Prospectus
en 16/03/2018
Annual Report
en 31/12/2020

Please refer to the below issuer website for further documents.

https://www.vandapharma.com

Financials

Income Statement
USD201520162017201820192020
Revenue (m)109.93146.02165.08193.12227.19248.17
Operating Income (m)-40.19-18.57-16.9021.7422.8127.24
Net Income (m)-39.87-18.01-15.5725.21115.5523.34
Basic EPS-0.94-0.41-0.350.502.170.43
Avg. Diluted Shares Outstanding (m)42.2543.4544.7453.0554.8555.19
Balance Sheet
USD201520162017201820192020
Current Assets (m)166.55174.18169.86299.13354.14409.15
Non Current Assets (m)46.5036.2035.5733.00129.61124.31
Total Assets (m)213.05210.37205.43332.13483.75533.46
Current Liabilities (m)51.3250.3270.3653.0259.5165.94
Total Liabilities (m)------
Total Equity (m)133.03131.33131.39275.42410.95453.27
Cash Flows
USD201520162017201820192020
Operating Cash Flows (m)12.45-8.10-1.9829.9945.9551.78
Capital Expenditure (m)-2.53-1.41-1.66-25.37-1.02-1.80
Figures are quoted in USD unless stated otherwise
0.16 (0.90%)
$
18.02
Last Price